Study: Vaccination linked to lower risk of post-COVID

The risk of developing post-COVID after a COVID infection was reduced in vaccinated people, according to a new study from the University of Gothenburg.

How to optimise your liquid handling results

In dispensing or pipetting applications in laboratory automation, it is important to obtain reliable results, which are analysed by calculating the accuracy and...

Immunterapibolag tar in 339 miljoner

Immunterapibolaget Asgard Therapeutics har tagit in 30 miljoner euro, motsvarande omkring 339 miljoner kronor, i en finanseringsrunda.

Umeåbolag växer och nyanställer

Umeåföretaget Uman Diagnostics utökar personalstyrkan och anställer Maria Hörnberg som Assay Development Scientist och Ronja Lindgren som Laboratory Engineer.

Here are the pharmaceutical companies best prepared for AI

How well prepared are pharmaceutical companies in the field of artificial intelligence? That is what a new analysis has tried to evaluate.

Aqilions licensdeal gav eko – ”Det var ett litet svenskt biotech som gjorde det”

Var extremt noga med dina vetenskapliga data, men lägg minst lika mycket tid och kraft på affärsutveckling. Det rådet ger Aqilions vd Sarah Fredriksson till bio...

Tirzepatide approved for obesity by the FDA – to be branded as Zepbound

Diabetes drug tirzepatide has now also been approved in the US for treating obesity.

Festo liquid dispensing: going fast and slow

Dispensing liquid with Festo equipment developed for automation can really be adapted to your needs

Life Science Sweden heads to the Oresund region! ‒ Hello there Michael Linnell

Life Science Sweden’s The Future of Swedish Danish Life Science and New Updates in Drug Formulation & Bioavailability meetings are coming up soon. We asked Mich...

Ny chefredaktör på Läkartidningen

Åsa Uhlin har utsetts till ny chefredaktör på Läkartidningen efter avgående Pär Sandell.

Bioarctic granted Japanese patent for Parkinson’s disease candidate

Bioarctic has been granted a Japanese patent for its antibodies targeting Parkinson’s disease.

Moberg och Karo i avtal om nagelsvampsbehandling – byter varumärkesnamn

Moberg Pharma har ingått ett licensavtal med Karo Healthcare om kommersialiseringen av nagelsvampsbehandlingen Terclara i Europa. Genom samarbetet får produkten...

Lucy Robertshaw: Artificial intelligence – is this really going to transform a patient’s life?

In a column Lucy Robertshaw reflects on how AI and new regulations will affect healthcare, innovation and the lives of future patients.

Nytt läkemedel mot fibromyalgi godkänt – första på 16 år

Amerikanska Tonix Pharma har fått FDA-godkännande för sitt läkemedel Tonmya för behandling av smärta relaterat till det kroniska tillståndet fibromyalgi. Läkeme...

Bought a tablet factory – and built his own empire

In 1995, Thomas Eldered was CEO of one of Pharmacia’s factories in the Stockholm area when the Swedish pharmaceutical giant, after a takeover, decided to move i...

Sepsisbolag tar in kapital

Bioteknikbolaget Aptahem, som utvecklar en behandling mot sepsis, har beslutat om en företrädesemission som kan ge bolaget upp till 34,6 miljoner kronor.

New Horizons in Biologics & Bioprocessing incl. Advanced Therapies: Stockholm (2026)

IVI’s Director General on establishing in Sweden: Will need up to 40 employees

The International Vaccine Institute, IVI, hopes to have its first staff on-site in Stockholm within a couple of months, says the institute’s Director General Je...

MedVasc and Scientific Solutions join forces to streamline FDA 510(k) regulatory process

MedVasc, an exciting MedTech startup company, and Scientific Solutions, a renowned consulting firm within Life Science, are pleased to announce a strategic part...

Easy integration of piezo valves for gas handling

Extremely energy-saving, silent and without any heat build-up – piezo technology offers many benefits for efficient and precise gas handling in medical technolo...

Alzinova tar steg mot fas II-studie i USA

Biofarmabolaget Alzinova hoppas kunna inleda en fas II-studie med sin vaccinkandidat mot Alzheimers under andra halvåret 2025.

Anna Törner: The minute between life and death

“I have never told anyone about this day that happened more than 20 years ago. But I sometimes reflect on what happened, on what might have happened. When I try...

Nytt blodprov för Alzheimers ska användas i primärvården

Den amerikanska läkemedelsmyndigheten FDA har godkänt Roches blodtest Elecsys för bedömning av tidig Alzheimers sjukdom. Testet är godkänt i EU sedan i juli.

Ny genterapi mot hemofili B godkänd i EU

CSL Behring presenterar nu den första genterapeutiska behandlingen mot blödarsjuka typ B, hemofili B. Vektorn är ett adeno-associerat virus.